Klivira
Request demo

Accelerating Pain Management Denial Appeal Automation

Klivira's platform delivers robust **pain management denial appeal automation**, transforming a high-friction workflow into a streamlined, data-driven process for interventional pain practices.

Revenue cycle leaders and prior authorization coordinators in pain management face significant challenges with denied claims, particularly for complex procedures and specialty medications. Manual appeal processes lead to delayed revenue, increased administrative burden, and potential write-offs. Klivira provides a targeted solution to automate and optimize this critical workflow.

The Unique Appeal Challenges in Pain Management

Pain management practices frequently encounter prior authorization denials for high-cost procedures and specialty drugs, including epidural/facet injections, spinal cord stimulators, and controlled substances like opioids. Common denial reasons often cite insufficient conservative-care trials, frequency limits on repeat injections, or gaps in imaging-symptom correlation, necessitating a precise and timely appeal strategy.

High-Volume Pain Management PA Categories Requiring Appeals

  • Spinal injections (epidural, facet, medial branch blocks, radiofrequency ablation)
  • Spinal cord stimulators (trial and permanent implantation)
  • Intrathecal pump implants for chronic pain
  • Kyphoplasty/vertebroplasty for vertebral compression fractures
  • Pain-management specialty drugs (e.g., buprenorphine, ziconotide/Prialt)

Klivira's Automated Appeal Workflow for Pain Management

Klivira's platform automates the entire denial appeal process, starting with denial classification using normalized CARC/RARC taxonomy. For pain management, this means intelligently routing denials related to procedures like SCS or specific drug categories, ensuring the correct appeal pathway is initiated based on payer-specific policies and clinical guidelines such as ASIPP and AAPM.

Key Automation Capabilities for Pain Management Appeals

  • FHIR-based documentation re-discovery to pull conservative-care trial notes, imaging, and pain severity scores (VAS, NRS)
  • Automated appeal-letter template assembly, generating clinician-reviewable drafts for clinical-necessity appeals
  • Payer-policy-aware pathway selection, ensuring the correct first-level, second-level, or peer-to-peer appeal is invoked
  • Automated status tracking with timely-filing window enforcement for all pain management appeals
  • Outcome capture and write-back into the EMR (as DocumentReference and Communication resources) for payment reprocessing

Addressing Specific Denial Drivers in Interventional Pain

Klivira's approach is tailored to pain management's specific denial patterns. For instance, our ASIPP-guideline-aware logic and SCS trial-phase documentation automation directly address 'conservative-care trial insufficient' denials. We also implement frequency-limit tracking for repeat injections, minimizing denials and streamlining appeals for these common interventional procedures. This precision significantly reduces documentation gaps and inconsistent appeal-letter quality.

Integration and Impact on Your Revenue Cycle

Integrating seamlessly with your EMR via SMART on FHIR, Klivira pulls the necessary clinical evidence and writes back appeal outcomes, closing the loop on your revenue cycle. By automating appeals for high-volume pain management procedures and specialty drugs, Klivira reduces the per-denial rework costs, as benchmarked by the CAQH Index, and improves overall financial performance.

Frequently asked questions

How does Klivira handle appeals for spinal cord stimulators?

Klivira automates appeals for spinal cord stimulators by leveraging our SCS trial-phase documentation automation. The platform retrieves required psychological evaluations and trial outcomes via FHIR, integrates ASIPP guidelines, and drafts comprehensive appeal letters, ensuring all payer-specific requirements for these complex devices are met.

Can Klivira automate appeals for frequency-limit denials on injections?

Yes, Klivira's system includes frequency-limit tracking for repeat injections like epidural and facet blocks. When a denial is issued based on frequency, the platform automatically generates an appeal letter that addresses the payer's specific policy, pulling relevant clinical notes to justify medical necessity.

Does the platform integrate with our EMR to pull clinical notes for appeals?

Absolutely. Klivira utilizes FHIR-based documentation re-discovery to seamlessly pull additional clinical documentation from your EMR. This includes conservative-care trial notes, imaging reports, pain severity tracking (VAS, NRS scores), and functional limitation documentation, ensuring appeal packets are complete without manual chart pulls.

How does Klivira ensure appeal letters meet payer-specific requirements?

Klivira's payer-policy library encodes per-payer appeal-pathway specifications and documentation requirements. The platform uses payer-template appeal-letter assembly, generating drafts that address specific denial reasons like CARC/RARC codes, and incorporates relevant clinical guidelines such as ASIPP and AAPM, which can be reviewed by a clinician before submission.

What role do clinical guidelines like ASIPP play in Klivira's appeal automation?

Klivira's platform is designed with ASIPP-guideline-aware conservative-care logic. For interventional pain procedures, the system understands and applies these guidelines to ensure that documentation for conservative-care trials, imaging correlation, and other requirements is accurately compiled and presented in appeal submissions, bolstering the case for medical necessity.

Related coverage

Other pain-management prior auth workflows

Ready to automate this workflow for this specialty?

See how Klivira automates prior authorizations for your team.

Request a demo